ArticleAnnals of translational medicine2022

Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin?

Jiangfeng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.